BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Mike Grey will speak on "What Are the Funding Sources and How to Apply" at the American Chemical Society meeting in San Diego, CA
News | 10. 09. 2010
